Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial-Reference-Cited by-同舟云学术

Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial

Published:2018-06-20 Issue:8 Volume:148 Page:1276-1284
ISSN:0022-3166
Container-title:The Journal of Nutrition
language:en
Short-container-title:

Author:

Bakhshimoghaddam Farnush¹,Shateri Kamran²,Sina Morad³,Hashemian Maryam⁴⁵⁶,Alizadeh Mohammad⁷^ORCID

Affiliation:

1. Student Research Committee, Department of Nutrition, Food and Beverages Safety Research Center, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

2. Department of Gastroenterology, Food and Beverages Safety Research Center, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

3. Department of Radiology, Food and Beverages Safety Research Center, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

4. Departments of Nutrition and Biochemistry, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran

5. Departments of Biochemistry, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran

6. Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran

7. Department of Nutrition, Food and Beverages Safety Research Center, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

Funder

Urmia University of Medical Sciences

Publisher

Oxford University Press (OUP)

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://academic.oup.com/jn/article-pdf/148/8/1276/25411189/nxy088.pdf

Reference50 articles.

1. The global NAFLD epidemic;Loomba;Nat Rev Gastroenterol Hepatol,2013

2. Prevalence of non-alcoholic fatty liver disease and its related factors in Iran;Moghaddasifar;Int J Organ Transplant Med,2016

3. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States;Le MH;PLoS One,2017

4. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012

5. Weight loss as a treatment for nonalcoholic fatty liver disease;Clark;J Clin Gastroenterol,2006

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: A systematic review and meta-analysis of randomized controlled trials;Pharmacological Research;2024-10

2. Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges;Engineering;2024-09

3. The Role of Probiotics in Managing Metabolic-Associated Fatty Liver Disease: An Updated Review;Current Research in Nutrition and Food Science Journal;2024-08-30

4. Effects of Synbiotic Administration on Gut Microbiome and Fecal Bile Acids in Dogs with Chronic Hepatobiliary Disease: A Randomized Case–Control Study;Veterinary Sciences;2024-08-10

5. The effects of probiotic supplementation and exercise training on liver enzymes and cardiometabolic markers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized clinical trials;Nutrition & Metabolism;2024-08-01